Juniper Genomics employs whole genome and transcriptome sequencing along with proprietary data analysis to enhance embryo selection in in vitro fertilization (IVF). By providing personalized insights based on comprehensive genetic data, the company increases the likelihood of successful embryo transfers, thereby improving IVF outcomes.
Funding
$2.8M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
In vitro fertilization (IVF) success rates are limited by the accuracy of current embryo testing methods, which often fail to identify viable embryos, leading to multiple transfer attempts and increased financial and emotional burden for aspiring parents. Existing euploid embryo testing methods only analyze a fraction of the data available from the embryo, resulting in a significant percentage of "normal" embryos failing to implant.
Solution
Juniper Genomics enhances embryo selection in IVF by employing whole genome and transcriptome sequencing, combined with proprietary data analysis, to provide a more comprehensive assessment of embryo viability. The company's patented technology integrates DNA, RNA, and parental information to generate a rich dataset focused on IVF success. This data is then processed and analyzed using a sophisticated algorithm to identify viable embryos with greater certainty, increasing the likelihood of a successful first embryo transfer and shortening the IVF journey.
Target Audience
The primary customers are fertility clinics and reproductive endocrinologists seeking to improve IVF success rates for their patients, as well as aspiring parents undergoing IVF treatment.
Features
- Whole genome and transcriptome sequencing for comprehensive embryo analysis
- Patented technology integrating DNA, RNA, and parental information
- Proprietary data analysis algorithms focused on predicting IVF success
- Identification of viable embryos with greater accuracy compared to traditional euploid testing
- Support for informed decision-making in embryo selection